Stephen Mark Tompkins
Affiliation: University of Georgia
- Protection against lethal influenza virus challenge by RNA interference in vivoStephen Mark Tompkins
Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
Proc Natl Acad Sci U S A 101:8682-6. 2004..These results indicate that RNA interference is promising for control of influenza virus infection, as well as other viral infections...
- Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1Stephen Mark Tompkins
Food and Drug Administration, Bethesda, Maryland, USA
Emerg Infect Dis 13:426-35. 2007..This M2 prime-boost vaccination conferred broad protection against challenge with lethal influenza A, including an H5N1 strain. Vaccination with M2, with key sequences represented, may provide broad protection against influenza A...